Abstract
Growth hormone is important for the development and function of the immune system, but there is controversy on whether growth hormone deficiency is associated to immune disorders. A model of isolated growth hormone deficiency may clarify if the lack of growth hormone is associated with increased susceptibility to infections, or with an altered responsiveness of the immune system. We have studied the frequency of infectious diseases and the immune function in adults with congenital, untreated isolated growth hormone deficiency. In a cross-sectional study, 35 adults with isolated growth hormone deficiency due to a homozygous mutation in the growth hormone releasing hormone receptor gene and 31 controls were submitted to a clinical questionnaire, physical examination serology for tripanosomiasis, leishmaniasis, HIV, tetanus, hepatitis B and C, and serum total immunoglobulin G, M, E and A measurement. The immune response was evaluated in a subset of these subjects by skin tests and response to vaccination for hepatitis B, tetanus, and bacillus Calmette-Guérin. There was no difference between the groups in history of infectious diseases and baseline serology. Isolated growth hormone deficiency subjects had lower total IgG, but within normal range. There was no difference in the response to any of the vaccinations or in the positivity to protein Purified Derived, streptokinase or candidin. Adult untreated isolated growth hormone deficiency does not cause an increased frequency of infectious diseases, and does not alter serologic tests, but is associated with lower total IgG levels, without detectable clinical impact.
Similar content being viewed by others
References
D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, A. Butler, The somatomedin hypothesis. Endocr. Rev. 22, 53–74 (2001)
E. Linehan, D.C. Fitzgerald, Ageing and the immune system: focus on macrophages. Eur. J. Microbiol. Immunol. 5, 14–24 (2015)
P. Smith, The effect of hypophysectomy upon the involution of the thymus in the rat. Anat. Rec. 47, 119–129 (1930)
C.J. Auernhammer, C.J. Strasburger, Effects of growth hormone and insulin-like growth factor I on the immune system. Eur. J. Endocrinol. 133, 635–645 (1995)
R. Clark, The somatogenic hormones and insulin-like growth factor I: stimulators of lymphopoiesis and immune function. Endocr. Rev. 18, 157–179 (1997)
Y. Yang, L. Guo, L. Ma, X. Liu, Expression of growth hormone and insulin-like growth factor in the immune system of children. Horm. Metab. Res. 31, 380–384 (1999)
D. Oberlin, C. Fellbaum, E. Eppler, Insulin-like growth factor I messenger RNA and protein are expressed in the human lymph node and distinctly confined to subtypes of macrophages, antigen-presenting cells, lymphocytes and endothelial cells. Immunology 128, 342–350 (2009)
C.J. Auernhammer, C. Fottner, D. Engelhardt, M. Bidlingmaier, C.J. Strasburger, M.M. Weber, Differential regulation of insulin-like growth factor-(IGF)I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells. Horm. Res. 57, 15–21 (2002)
N. Hattori, T. Saito, T. Yagyu, B.H. Jiang, K. Kitagawa, C. Inagaki, GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocr. Metab. 86, 4284–4291 (2001)
N. Hattori, Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm. IGF Res. 19, 187–197 (2009)
K. Van Bilsen, G.J. Driessen, R.A. Paus, E.V. Van de Vosse, K. Van Lom, M.C. Van Zelm, K.H. Lam, N.G. Hartwig, G.S. Baarsma, M. Van de Burg, P.M. Van Hagen, Low level IGF-1 and common variable immune deficiency: an unusual combination. Neth. J. Med. 66, 368–372 (2008)
E.M. Kofoed, V. Hwa, B. Little, K.A. Woods, C.K. Buckway, J. Tsubaki, K.L. Pratt, L. Bezrodnik, H. Jasper, A. Tepper, J. Heinrich, R.G. Rosenfeld, Growth-hormone insensitivity (GHI) associated with a STAT-5b mutation. N. Engl. J. Med. 349, 1139–1147 (2003)
J.L. Casanova, S.M. Holland, L.D. Notarangelo, Inborn errors of human JAKs and STATs. Immunity 36, 515–528 (2012)
R.C. Scalco, P.N. Pugliese-Pires, A.A.L. Jorge, STAT5B deficiency: a new growth hormone insensitivity syndrome associated to immunological dysfunction. Arq. Bras. Endocrinol. Metab. 57, 333–338 (2013)
V. Hwa, STAT5B deficiency: impacts on human growth and immunity. Growth Horm. IGF Res. 28, 16–20 (2016). doi:10.1016/j.ghir.2015.12.006
T.A. Fleisher, R.M. White, S. Broder, S.P. Nissley, R.M. Blaese, J.J. Mulvihill, G. Olive, T.A. Waldmann, X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N. Engl. J. Med. 302, 1429–1434 (1980)
D.M. Stewart, L. Tian, L.D. Notarangelo, D.L. Nelson, X-linked hypogammaglobinemia and isolated growth hormone deficiency: an update. Immunol. Res. 40, 262–270 (2008)
R. Shohreh, C.A. Pardo, F. Guaraldi, A.V. Schally, R. Salvatori, GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis. Endocrinology 152, 3803–3810 (2011)
R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips III, A.H. Souza, R.G. Gondo, S.P.A. Toledo, M.M. Conceição, M. Prince, H.D. Maheshwari, G. Baumann, M.A. Levine, Familial isolated growth hormone deficiency due to a novel mutation in the growth hormone releasing hormone receptor. J. Clin. Endocr. Metab. 84, 917–923 (1999)
M.H. Aguiar-Oliveira, F.T. Oliveira, R.M.C. Pereira, C.R.P. Oliveira, A. Blackford, E.H.O. Valença, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C.R. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the ghrh receptor gene. J. Clin. Endocr. Metab. 95, 714–721 (2010)
A.R. Ahmed, D.A. Blose, Delayed-type hypersensitivity skin testing. Arch. Dermatol. 119, 934–945 (1983)
Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis (Brasil). técnicas de aplicação e leitura da prova tuberculínica. (Ministério da Saúde, Distrito Federal, Brasília), 2014)
A.Z. Bluming, J.L. Ziegler, L. Fass, R.B. Herberman, Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study. Clin. Exp. Immunol. 9, 713–719 (1971)
O. Kecha, F. Brilot, H. Martens, N. Franchimont, C. Renard, R. Greimers, M.P. Defresne, R. Winkler, V. Geenen, Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures. Endocrinology 141, 1209–1217 (2000)
T. Taguchi, H. Takenouchi, J. Matsui, W.R. Tang, M. Itagaki, Y. Shiozawa, K. Suzuki, S. Sakaguchi, Y.U. Ktagiri, T. Takahashi, H. Okita, J. Fujimoto, N. Kiyokawa, Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell development. Exp. Hematol. 34, 508–518 (2006)
A. Mukherjee, M. Helbert, W.D.J. Ryder, R. Borrow, J.R.E. Davis, S.M. Shalet, Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults. Clin. Exp. Immunol. 156, 271–277 (2009)
G.L. Spadoni, P. Rossi, W. Ragno, E. Galli, S. Cianfarani, C. Galasso, B. Boscherini, Immune function in growth hormone-deficient children treated with biosynthetic growth hormone. Acta Paediatr. Scand. 80, 75–79 (1991)
K. Dorshkind, N.D. Horseman, The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 21, 292–312 (2000)
L. Matera, Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci. 59, 599–614 (1996)
A. De Bellis, A. Bizzarro, R. Pivonello, G. Lombardi, A. Bellastella, Prolactin and autoimmunity. Pituitary 8, 25–30 (2005)
V. Abassi, J.A. Bellanti, Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone. Pediatr. Res. 19, 299–301 (1985)
M.H. Aguiar-Oliveira, M.S. Gill, E.S.A. Barretto, M.R.S. Alcântara, F. Miraki-Moud, C.A. Menezes, A.H.O. Souza, C.E. Martinelli, F.A. Pereira, R. Salvatori, M.A. Levine, S.M. Shalet, C. Camacho-Hubner, P.E. Clayton, Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF binding proteins, and ternary complex formation throughout life. J. Clin. Endocr. Metab. 84, 4118–4126 (1999)
R. Salvatori, M.G. Serpa, G. Parmigiani, A.V.O. Britto, J.L.M. Oliveira, C.R.P. Oliveira, C.M. Prado, C.T. Farias, J.C. Almeida, T.A.R. Vicente, M.H. Aguiar-Oliveira, GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome. J. Endocrinol. Invest. 29, 805–808 (2006)
M. Menezes, R. Salvatori, L.D. Melo, I.E.S. Rocha, C.R.P. Oliveira, R.M.C. Pereira, A.H.O. Souza, E.H.O. Valença, E.V. Melo, V.C. Campos, F.O. Costa, M.H. Aguiar-Oliveira, Prolactin and sex steroids levels in congenital lifetime isolated GH deficiency. Endocrine 44, 207–211 (2013)
K.W. Kelley, D.A. Weigent, R. Kooijman, Protein hormones and immunity. Brain Behav. Immun. 21, 384–392 (2007)
Y.K. Fu, S. Arkins, G. Fuh, B.C. Cunningham, J.A. Wells, S. Fong, M.J. Cronin, R. Dantzer, K.W. Kelley, Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J. Clin. Invest. 89, 451–457 (1992)
P.R. Ogershok, M.B. Hogan, J.E. Welch, W.T. Corder, N.W. Wilson, Spectrum of illness in pediatric common variable immunodeficiency. Ann. Allergy Asthma Immunol. 97, 653–656 (2006)
Z. Laron, Lifespan and Mortality of patients with Laron Syndrome. In: Z. Laron, J.J. Kopchick, (eds) Laron Syndrome from Man to Mouse: Lessons from Clinical Experimental Experience, pp. 341–342. Springer-Verlag, Berlin Heidelberg (2011)
C. Prakash, R. Bhatia, S. Kumari, T. Verghese, K. Datta, Response to hepatitis B vaccination in high-risk population. J. Commun. Dis. 32, 17–21 (2000)
D. Lithgow, C. Cole, A reinvestigation of seroconversion rates in hepatits b–vaccinated individuals. Biol. Res. Nurs. 17(1), 49–54 (2014). doi:10.1177/1099800414524619
J.N. Zuckerman, Protective efficacy, immunotherapeutic potential, and safety of hepatitis b vaccines. J. Med. Virol. 78, 169–177 (2006)
C.-F. Jan, K.-C. Huang, Y.-C. Chien, D.E. Greydanus, H.D. Davies, T.-Y. Chiu, L.-M. Huang, C.-J. Chen, D.-S. Chen, Determination of immune memory to hepatitis b vaccination through early booster response in college students. Hepatology 51, 1547–1554 (2010)
R.J. Thomas, G.J. Fletcher, H. Kirupakaran, M.P. Chacko, S. Thenmozhi, C.E. Eapen, G. Chandy, P. Abraham, Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital. Indian J. Med. Microbiol. 33, 32–36 (2015)
J. Guevara-Aguirre, M. Guevara-Aguirre, J. Saavedra, G. Bernstein, Low serum levels of IGF-1, BP3 and ALS are associated to severe short stature, obesity premature aging, increased cardiovascular mortality and absence of cancer in the Ecuadorian cohort of Laron syndrome subjects. Hormone Res. 68(Suppl. 1), 175 (2007)
R.G. Rosenfeld, L. Arlan, J. Guevara-Aguirre, Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr. Rev. 15, 369–390 (1994)
M. Kanariou, E. Petridou, M. Liatsis, K. Revinthi, K. Mandalenaki-Lambrou, D. Trichopoulos, Age patterns of immunoglobulins G, A & M in healthy children and the influence of breast feeding and vaccination status. Pediatr. Allergy Immunol. 6, 24–29 (1995)
M. Menezes, R. Salvatori, C.R.P. Oliveira, R.M.C. Pereira, A.H.O. Souza, L.M.A. Nobrega, E. Cruz, A.C. do, M. Menezes, E.O. Alves, M.H. Aguiar-Oliveira, Climacteric in untreated isolated growth hormone deficiency. Menopause 15, 743–747 (2008)
C.R.P. Oliveira, R. Salvatori, L.M.A. Nóbrega, E.O.M. Carvalho, M. Menezes, C.T. Farias, A.V.O. Britto, R.M.C. Pereira, M.H. Aguiar-Oliveira, Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene. Clin. Endocrinol. (Oxf.) 69, 153–158 (2008)
M. Alba, D. Fintini, R. Salvatori, Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice. Growth Horm. IGF Res. 15, 275–282 (2005)
L. Zhao, L. Liu, B. Guo, B. Zhu, Regulation of adaptive immune responses by guiding cell movements in the spleen. Front Microbiol. 6, 645–650 (2015)
R. Lindsay, M. Feldkamp, D. Harris, J. Robertson, M. Rallison, Utah growth study: growth standards and the prevalence of growth hormone deficiency. J. Pediatr. 125, 29–35 (1994)
Acknowledgments
The authors thank the Associação do Crescimento Físico e Humano de Itabaianinha, for assistance.
Funding
This work was supported by Foundation Research and Technological Innovation of Sergipe-FAPITEC/SE/FUNTEC/CNPq No. 12/2009 (to A.R.J.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
R.S. serves in the advisory board of Novo Nordisk and Pfizer.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Campos, V.C., Barrios, M.R., Salvatori, R. et al. Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency. Endocrine 54, 182–190 (2016). https://doi.org/10.1007/s12020-016-1061-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1061-z